DNTH logo

Dianthus Therapeutics, Inc. (DNTH) Selling, General & Administrative Expenses

Annual SG&A:

$0.00-$18.16M(-100.00%)
December 31, 2024

Summary

  • As of today (October 3, 2025), DNTH annual SG&A is $0.00, with the most recent change of -$18.16 million (-100.00%) on December 31, 2024.
  • During the last 3 years, DNTH annual SG&A has fallen by -$27.93 million (-100.00%).
  • DNTH annual SG&A is now -100.00% below its all-time high of $28.09 million, reached on December 1, 2020.

Performance

DNTH SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHincome statement metrics

Quarterly SG&A:

$0.00-$7.34M(-100.00%)
June 30, 2025

Summary

  • As of today (October 3, 2025), DNTH quarterly SG&A is $0.00, with the most recent change of -$7.34 million (-100.00%) on June 30, 2025.
  • Over the past year, DNTH quarterly SG&A has dropped by -$6.00 million (-100.00%).
  • DNTH quarterly SG&A is now -100.00% below its all-time high of $8.72 million, reached on September 30, 2023.

Performance

DNTH Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHincome statement metrics

TTM SG&A:

-$759.78M-$114.75M(-17.79%)
June 30, 2025

Summary

  • As of today (October 3, 2025), DNTH TTM SG&A is -$759.78 million, with the most recent change of -$114.75 million (-17.79%) on June 30, 2025.
  • Over the past year, DNTH TTM SG&A has dropped by -$784.77 million (-3140.09%).
  • DNTH TTM SG&A is now -1247.80% below its all-time high of -$56.37 million.

Performance

DNTH TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

DNTH Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-100.0%-100.0%-3140.1%
3Y3 Years-100.0%-100.0%-2790.2%
5Y5 Years-100.0%-100.0%-2893.2%

DNTH Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.0%at low-100.0%at low-93.7%+46.6%
5Y5-Year-100.0%at low-100.0%at low-93.7%+46.6%
All-TimeAll-Time-100.0%at low-100.0%at low-1247.8%+46.6%

DNTH Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$13.87M(-30.2%)
Mar 2025
-
$7.34M(>+9900.0%)
$19.86M(+9.3%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$18.16M(-20.3%)
Sep 2024
-
$6.53M(+8.9%)
$22.80M(-8.8%)
Jun 2024
-
$6.00M(+6.3%)
$24.99M(+16.3%)
Mar 2024
-
$5.64M(+21.8%)
$21.49M(+18.3%)
Dec 2023
$18.16M(+169.3%)
$4.63M(-46.9%)
$18.16M(+16.7%)
Sep 2023
-
$8.72M(+250.0%)
$15.56M(+72.0%)
Jun 2023
-
$2.49M(+7.8%)
$9.05M(-30.6%)
Mar 2023
-
$2.31M(+13.5%)
$13.04M(-27.6%)
Dec 2022
$6.74M(-75.9%)
$2.04M(-7.8%)
$18.01M(-21.7%)
Sep 2022
-
$2.21M(-65.9%)
$23.00M(-18.6%)
Jun 2022
-
$6.48M(-11.1%)
$28.24M(-0.0%)
Mar 2022
-
$7.29M(+3.7%)
$28.24M(+1.1%)
Dec 2021
$27.93M
-
-
Dec 2021
-
$7.03M(-5.7%)
$27.93M(+0.8%)
Sep 2021
-
$7.45M(+15.0%)
$27.71M(+3.2%)
Jun 2021
-
$6.48M(-7.0%)
$26.85M(-3.3%)
DateAnnualQuarterlyTTM
Mar 2021
-
$6.97M(+2.3%)
$27.77M(-1.1%)
Dec 2020
$28.09M(+18.2%)
$6.81M(+3.2%)
$28.09M(+3.3%)
Sep 2020
-
$6.59M(-10.9%)
$27.20M(+1.8%)
Jun 2020
-
$7.40M(+1.7%)
$26.73M(+5.9%)
Mar 2020
-
$7.28M(+22.9%)
$25.23M(+6.2%)
Dec 2019
$23.76M(+27.6%)
$5.92M(-3.2%)
$23.76M(+1.6%)
Sep 2019
-
$6.12M(+3.6%)
$23.38M(+3.7%)
Jun 2019
-
$5.91M(+1.6%)
$22.54M(+7.5%)
Mar 2019
-
$5.81M(+4.9%)
$20.98M(+12.7%)
Dec 2018
$18.62M(+137.9%)
$5.54M(+4.8%)
$18.62M(+42.3%)
Sep 2018
-
$5.28M(+21.7%)
$13.08M(+36.2%)
Jun 2018
-
$4.34M(+25.6%)
$9.60M(+33.8%)
Mar 2018
-
$3.46M(+91.5%)
$7.18M(+37.8%)
Dec 2017
$7.83M(+124.6%)
-
-
Sep 2017
-
$1.80M(-5.7%)
$5.21M(+53.0%)
Jun 2017
-
$1.92M(+28.6%)
$3.40M(+128.6%)
Mar 2017
-
$1.49M
$1.49M
Dec 2016
$3.49M
-
-

FAQ

  • What is Dianthus Therapeutics, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. annual SG&A year-on-year change?
  • What is Dianthus Therapeutics, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. quarterly SG&A year-on-year change?
  • What is Dianthus Therapeutics, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. TTM SG&A year-on-year change?

What is Dianthus Therapeutics, Inc. annual SG&A?

The current annual SG&A of DNTH is $0.00

What is the all-time high annual SG&A for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high annual SG&A is $28.09M

What is Dianthus Therapeutics, Inc. annual SG&A year-on-year change?

Over the past year, DNTH annual SG&A has changed by -$18.16M (-100.00%)

What is Dianthus Therapeutics, Inc. quarterly SG&A?

The current quarterly SG&A of DNTH is $0.00

What is the all-time high quarterly SG&A for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high quarterly SG&A is $8.72M

What is Dianthus Therapeutics, Inc. quarterly SG&A year-on-year change?

Over the past year, DNTH quarterly SG&A has changed by -$6.00M (-100.00%)

What is Dianthus Therapeutics, Inc. TTM SG&A?

The current TTM SG&A of DNTH is -$759.78M

What is the all-time high TTM SG&A for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high TTM SG&A is -$56.37M

What is Dianthus Therapeutics, Inc. TTM SG&A year-on-year change?

Over the past year, DNTH TTM SG&A has changed by -$784.77M (-3140.09%)
On this page